Stay updated on Pembrolizumab/Gemcitabine in ABC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Gemcitabine in ABC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The NIH website transition announcement banner is no longer shown above the ClinicalTrials.gov page, which continues to display a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-08T13:26:04.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 on the ClinicalTrials.gov page.
    Difference
    0.2%
    Check dated 2026-11-01T14:37:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T13:35:38.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:51:12.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer’s displayed site revision advances from v3.7.0 to v3.7.1 while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T13:56:10.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study record content. This blocks access to the NCT03025880 trial details on ClinicalTrials.gov.
    Difference
    21%
    Check dated 2026-09-20T19:42:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Gemcitabine in ABC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Gemcitabine in ABC Clinical Trial page.